These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 9852415
1. NA1/NA2 antisera inhibit FcgammaRI- but not FcgammaRII- mediated phagocytosis. Flesch BK, Maass W, Neppert J. Vox Sang; 1998; 75(3):247-52. PubMed ID: 9852415 [Abstract] [Full Text] [Related]
2. Fcgamma receptor-mediated immune phagocytosis depends on the class of FcgammaR and on the immunoglobulin-coated target cell. Flesch BK, Vöge K, Henrichs T, Neppert J. Vox Sang; 2001; 81(2):128-33. PubMed ID: 11555474 [Abstract] [Full Text] [Related]
3. Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes. Bredius RG, Fijen CA, De Haas M, Kuijper EJ, Weening RS, Van de Winkel JG, Out TA. Immunology; 1994 Dec; 83(4):624-30. PubMed ID: 7875742 [Abstract] [Full Text] [Related]
4. Fcgamma receptors exhibit different phagocytosis potential in human neutrophils. Rivas-Fuentes S, García-García E, Nieto-Castañeda G, Rosales C. Cell Immunol; 2010 Dec; 263(1):114-21. PubMed ID: 20356573 [Abstract] [Full Text] [Related]
11. Little impact of donor/recipient major mismatch for neutrophil-specific antigen NA2 on neutrophil recovery after allogeneic SCT. Inukai T, Goi K, Tezuka T, Uno K, Nemoto A, Takahashi K, Sato H, Akahane K, Hirose K, Honna H, Kuroda I, Kagami K, Nakamoto K, Taniguchi K, Nakazawa S, Sugita K. Bone Marrow Transplant; 2009 Feb; 43(3):229-35. PubMed ID: 18806835 [Abstract] [Full Text] [Related]
12. Fcgamma receptor polymorphisms determine the magnitude of in vitro phagocytosis of Streptococcus pneumoniae mediated by pneumococcal conjugate sera. Jansen WT, Breukels MA, Snippe H, Sanders LA, Verheul AF, Rijkers GT. J Infect Dis; 1999 Sep; 180(3):888-91. PubMed ID: 10438387 [Abstract] [Full Text] [Related]
13. Chemical treatment of anti-D results in improved efficacy for the inhibition of Fcgamma receptor-mediated phagocytosis. Foo AH, Ramkumar S, Helke S, Branch DR. Transfusion; 2007 Dec; 47(12):2250-9. PubMed ID: 17714414 [Abstract] [Full Text] [Related]
14. FcgammaRIIa expression with FcgammaRI results in C-reactive protein- and IgG-mediated phagocytosis. Bodman-Smith KB, Gregory RE, Harrison PT, Raynes JG. J Leukoc Biol; 2004 Jun; 75(6):1029-35. PubMed ID: 15075346 [Abstract] [Full Text] [Related]
15. Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities. Salmon JE, Edberg JC, Kimberly RP. J Clin Invest; 1990 Apr; 85(4):1287-95. PubMed ID: 1690757 [Abstract] [Full Text] [Related]
16. Effective phagocytosis and killing of Candida albicans via targeting FcgammaRI (CD64) or FcalphaRI (CD89) on neutrophils. van Spriel AB, van den Herik-Oudijk IE, van Sorge NM, Vilé HA, van Strijp JA, van de Winkel JG. J Infect Dis; 1999 Mar; 179(3):661-9. PubMed ID: 9952373 [Abstract] [Full Text] [Related]
19. Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcgammaRIIIb and MHC class II expression on the phagocytotic neutrophils. Shibata-Koyama M, Iida S, Misaka H, Mori K, Yano K, Shitara K, Satoh M. Exp Hematol; 2009 Mar; 37(3):309-21. PubMed ID: 19218011 [Abstract] [Full Text] [Related]